Search, analyze & compare
My selected companies
Adjust valuation method
![]()
Detail of CVRx, Inc.
CEO
Mr. Nadim Yared
Employees
109
Industry
Medical Devices
Sector
Healthcare
Market cap
$339M
Company details
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$47.26M
Cost of goods (CoG)
-$7.48M
Gross profit (GP)
$39.77M
Operating expense (OE)
-$98.65M
Research and development (R&D)
-$10.57M
General and administrative (G&A)
-$88.08M
Operating income (OI)
-$58.88M
Other income expense (OIE)
-$4.02M
Pretax income (PI)
-$58.31M
Tax (TAX)
-$165,000.00
Net income (NI)
-$58.48M
Stock vs Industry average
-
Industry average
Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$2.57
Margin profit
-123.75%
52 week low
$6.49
52 week high
$31.440001
50-day simple moving average
$14.46
200-day simple moving average
$10.36
Percent held by insiders
4.40%
Percent held by institutions
71.94%
Dividend yield
0.00%
